Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study - Tatsuo Furukawa, Miwako Narita, Tadashi Koike, Kazue Takai, Koichi Nagai, Masashi Kobayashi, Satoru Koyama, Yoshinobu Seki, Hoyu Takahashi, Masahiro Fujiwara, Kenji Kishi, Koji Nikkuni, Noriatsu Isahai, Wataru Higuchi, Nobuhiko Nomoto - Dissemin

Language
Login

Published in

Springer, International Journal of Hematology, 3(93), p. 336-343

DOI: 10.1007/s12185-011-0774-2

Links

Springer

Tools

Export citation

Search in Google Scholar

Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study

Journal article published in 2011 by Tatsuo Furukawa, Miwako Narita, Tadashi Koike, Kazue Takai, Koichi Nagai, Masashi Kobayashi, Satoru Koyama, Yoshinobu Seki, Hoyu Takahashi, Masahiro Fujiwara, Kenji Kishi, Koji Nikkuni, Noriatsu Isahai, Wataru Higuchi, Nobuhiko Nomoto and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO